Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
William Morris, MD, is Staff in the Department of Hospital Medicine at Cleveland Clinic, appointed in 2006. He was certified by the American Board of Internal Medicine in 2007.
He was named Director of Clinical Informatics in 2007, with an area of focus on implementation, optimization and innovation and promoted to Associate Chief Medical Information Officer in 2012. A prolific inventor and innovator, Dr. Morris started and currently directs the Clinical Solutions Center at Cleveland Clinic. This highly specialized team brings experts in computer science, hardware and software engineers and clinicians to develop the next generation of clinical care tools. In 2008 Dr. Morris was named Innovator of the year for his work in implementing physician order entry for Cleveland Clinic and also received Innovator awards in 2010, 2011 and 2012 for work around healthcare software. He is active on numerous advisory committees include medical-legal, quality and safely committees and co-chairs distance health and mHealth initiatives within the health system. He continues his clinical role as a Hospitalist within the Medicine Institute as well as a Clinical Assistant Professor of the Cleveland Clinic Lerner College of Medicine and Case Western Reserve School of Medicine.
hospitalist medicine, medical education, medical informatics
Innovations & Patents
United States Patent No. 6,534,262. Solid Phase Technique for Selectively Isolating Nucleic Acids. Invented and patented nucleic acid purification system. Patent founded Agencourt Bioscience, Inc., acquired by Beckman Coulter in 2005.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/1/2016, Dr. Morris has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.